<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) is a group of blood-related <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> caused by disorders of hematopoietic stem cells (<z:chebi fb="15" ids="50443">HSCs</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>It is mainly characterized by the ineffective hematopoiesis </plain></SENT>
<SENT sid="2" pm="."><plain>Many <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients will transform into <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) with poor prognosis, often due to <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, <z:mp ids='MP_0001914'>hemorrhage</z:mp> and <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>However, the molecular mechanism underlying the transformation remains unknown </plain></SENT>
<SENT sid="4" pm="."><plain>MicroRNAs (miRNAs), a class of recently discovered noncoding <z:chebi fb="40" ids="33697">RNA</z:chebi> genes that post-transcriptionally regulate gene expression, are considered playing an important role in regulating gene translation during development </plain></SENT>
<SENT sid="5" pm="."><plain>Aberrant expression of miRNAs plays an important role in the mutation of <z:chebi fb="15" ids="50443">HSCs</z:chebi> and their transformation to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> stem cells, suggesting an important mechanism of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> pathogenesis and its transformation to <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>So far, few studies have focused on molecular mechanisms of the transformation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The role of miRNAs in the transformation needs to be fully understood </plain></SENT>
<SENT sid="8" pm="."><plain>Here, we reviewed the molecular mechanism of miRNA involvement in the damage of <z:chebi fb="15" ids="50443">HSCs</z:chebi>, the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and its transformation to <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>These results will be of theoretical importance for understanding the mechanism underlying the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and have potential applications in the prevention and treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and in preventing its transformation to <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
</text></document>